Speed Medical results, Q1 2022
Net profit, assets, equity and cash flow for Q1 2022, against the same period a year earlier, from the published financial statements.
Net profit-38.41 millionEGP · −193.9% vs the same period a year earlier
Total assets711 millionEGP · +28.7% vs the same period a year earlier
Shareholders' equity388 millionEGP · −1.1% vs the same period a year earlier
Operating cash flow-3.91 millionEGP · −104.3% vs the same period a year earlier
In short
- Speed Medical's net profit for Q1 2022 was about -38.41 million EGP, down −193.9% from 40.92 million EGP in Q1 2021.
- Total assets at the end of Q1 2022 were about 711 million EGP, and shareholders' equity about 388 million EGP.
- Operating cash flow for Q1 2022 was negative at 3.91 million EGP.
Key lines against the same period a year earlier
This periodQ1 2021Change
Net profit-38.41 million40.92 million−193.9%
Gross profit31.05 million34.73 million−10.6%
Total assets711 million553 million+28.7%
Total liabilities324 million161 million+101.1%
Shareholders' equity388 million392 million−1.1%
Total liabilities and equity711 million553 million+28.7%
Operating cash flow-3.91 million90.07 million−104.3%
Investing cash flow-39.13 million-140 million+72.1%
Financing cash flow-49.1 million83.96 million−158.5%
Net change in cash-92.14 million33.7 million−373.4%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Speed Medical's Q2 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy